PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26222F0185Specialty medication — Actelion Pharmaceuticals Us Inc

Actelion Pharmaceuticals Us Inc holds $5.4M across 106 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 1 related award under parent 36F79719D0142. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Feb 4, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

262-Network Contract Office 22 (36C262)
Awarding office
Actelion Pharmaceuticals Us Inc
Recipient
Feb 4, 2023
PoP end
$343K
Obligated
$351K
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Actelion Pharmaceuticals Us Inc — $90

Contract facts

Federal
Contract number36C26222F0185
Also listed as36C262-22-F-0185
Also listed as36F79719D0142-36C26222F0185
Agency262-Network Contract Office 22 (36C262)
Awarding office262-Network Contract Office 22 (36C262)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentActelion Pharmaceuticals Us Inc
CAGE33TN9
UEIH5BMHLMMNA28
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79719D0142
Place of performanceMEMPHIS TN
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startFeb 4, 2022
PoP end (current)Feb 4, 2023
Obligated$343K
Current value$351K
Potential value$351K

SPECIALTY MEDICATION is a federal award for 262-Network Contract Office 22 (36C262) held by Actelion Pharmaceuticals Us Inc. Estimated value $351K ($343K obligated). Current period of performance ends Feb 4, 2023. Last award drew 1 bidder. Place of performance: MEMPHIS TN.

Recompete timing

Public
Past PoP end (1294 days ago)

Current PoP ended Feb 4, 2023 (1294 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Actelion Pharmaceuticals Us Inc$5.4M obligated across 106 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($5.4M) · all agencies
Department of Veterans Affairs (VA)$3.2M · 59%Department of Justice (DOJ)$2.2M · 41%
Open full company profile

Related awards

Same parent · incumbent
36C26026F0017
UPTRAVI 800MCG TABS
$407K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26222F0185?

36C26222F0185 (Specialty medication) is a 262-Network Contract Office 22 (36C262) award with a potential value of $351K, currently held by Actelion Pharmaceuticals Us Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C262-22-F-0185?

36C262-22-F-0185 is the dashed form of PIID 36C26222F0185 (Specialty medication), held by Actelion Pharmaceuticals Us Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26222F0185?

262-Network Contract Office 22 (36C262) awarded 36C26222F0185 to Actelion Pharmaceuticals Us Inc (potential $351K).

Who is the incumbent on 36C26222F0185?

Actelion Pharmaceuticals Us Inc is the incumbent with $5.4M across 106 related awards in SCOUT’s public footprint. The current period of performance ends Feb 4, 2023.

When does Actelion Pharmaceuticals Us Inc’s 36C26222F0185 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 4, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26222F0185